Invitation to Invest in a Breakthrough Medical Technology
From:
A physician and inventor with a track record of nearly 1,000 registered patents and multiple companies that have successfully executed real-world exits.
The Medical Challenge
Currently, patients requiring blood tests must undergo repeated needle sticks—sometimes twice a day.
During hospitalization, patients often receive fluids and medications via a permanent infusion needle, but this same access cannot be used to draw blood.
As a result, patients endure repeated needle insertions, causing pain, bruising, bleeding, and negatively impacting both the hospital experience and overall health.
The Innovative Solution
Our technology features a flexible, next-generation needle integrated with an intelligent “guide.”
On the first insertion, as soon as blood is detected in the collection tube, the guide identifies the vein, adapts to its structure—even if it is curved—and precisely directs the needle into it.
This ensures immediate and safe venous access with every insertion—eliminating repeated attempts, unnecessary pain, and significantly saving medical staff time.
Development Status
• FDA-approved patent
• Product in active production
Investment Objective
The entrepreneur seeks capital to:
• Implement further product improvements and adaptations
• Expand production lines for mass manufacturing
• Prepare for a strategic sale (exit) at a substantially higher valuation than the current one
Investment Details
• Minimum investment: $200,000
• Expected exit: within 2–3 years
• Anticipated return: approximately 80% per year on invested capital (bank-verified)
• Equity: Each $1 million investment represents 1/64 ownership of the company
Contact Information
Thank you very much.
Nisim Ezra, Engineer, Initiator, Consultant.
+972 54 4333470
Reshet Eshkolot Ltd.
resheteshkolot@gmail.com